绝经后铁代谢的变化对骨密度的影响
The Effect on Bone Mineral Density of Iron Metabolism Changes in Postmenopausal Women
摘要: 骨质疏松症(OP)由于其在老年人中的高发病率和高致骨折率，长期以来一直受到广泛的关注。随着世界各国人口老龄化的到来及加剧，骨质疏松症的患病率逐年上升，绝经后妇女由于体内雌激素的减少，对破骨细胞的分化和骨吸收的抑制作用降低，加速了骨量的流失，易导致绝经后骨质疏松症。体内铁含量水平及铁代谢与骨代谢有着密切的联系，不管是体内铁增多还是铁缺乏都会影响破骨细胞和成骨细胞的分化和活性，从而促进骨质流失，但对于体内铁代谢是如何影响骨密度及骨代谢，本综述简要阐述了体内铁含量及铁代谢对骨密度及骨代谢影响的有关机制，从而为铁相关性绝经后骨质疏松症的研究、预防及治疗提供新的临床思路。
Abstract: Osteoporosis (OP) has been widely concerned for a long time because of its high incidence and frac-ture rate in the elderly. With the arrival and aggravation of the aging of the world’s population, the prevalence of osteoporosis is increasing year by year. Because of the reduction of estrogen in post-menopausal women, the inhibition of osteoclast differentiation and bone resorption is reduced, which accelerates the loss of bone mass and easily leads to postmenopausal osteoporosis. The level of iron content and iron metabolism in the body are closely related to bone metabolism. Both iron increase and iron deficiency in the body will affect the differentiation and activity of osteoclasts and osteoblasts, thus promoting bone loss. However, how iron metabolism in the body affects bone den-sity and bone metabolism is briefly described in this review, It provides a new clinical idea for the research, prevention and treatment of iron related postmenopausal osteoporosis.
文章引用：姚淑萍, 赵成玉. 绝经后铁代谢的变化对骨密度的影响[J]. 临床医学进展, 2023, 13(6): 9743-9750. https://doi.org/10.12677/ACM.2023.1361364

参考文献

[1] Riggs, B.L., Khosla, S. and Melton III, L.J. (2002) Sex Steroids and the Construction and Conservation of the Adult Skeleton. Endocrine Reviews, 23, 279-302. [Google Scholar] [CrossRef] [PubMed]
[2] Drever, A. (2009) Bone Health and Osteoporosis. Practice Nursing, 38, 13-22.
[3] Riggs, B.L. (2000) The Mechanisms of Estrogen Regula-tion of Bone Resorption. Journal of Clinical Investigation, 106, 1203-1204. [Google Scholar] [CrossRef] 
[4] Syed, F. and Khosla, S. (2005) Mechanisms of Sex Steroid Effects on Bone. Biochemical and Biophysical Research Communications, 328, 688-696. [Google Scholar] [CrossRef] [PubMed]
[5] Frenkel, B., Hong, A., Baniwal, S.K., et al. (2010) Regulation of Adult Bone Turnover by Sex Steroids. Journal of Cellular Physiology, 224, 305-310. [Google Scholar] [CrossRef] [PubMed]
[6] Hofbauer, L.C. and Schoppet, M. (2004) Clinical Implications of the Osteo-protegerin/RANKL/RANK System for Bone and Vascular Diseases. JAMA, 292, 490-495. [Google Scholar] [CrossRef] [PubMed]
[7] Zhao, J., Huang, M., Zhang, X., et al. (2019) MiR-146a Deletion Pro-tects From Bone Loss in OVX Mice by Suppressing RANKL/OPG and M-CSF in Bone Microenvironment. Journal of Bone and Mineral Research, 34, 2149-2161. [Google Scholar] [CrossRef] [PubMed]
[8] Cheng, C.-H., Chen, L.-R. and Chen, K.-H. (2022) Osteoporosis due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. International Journal of Molecular Sciences, 23, Article No. 1376. [Google Scholar] [CrossRef] [PubMed]
[9] Shi, C., Luo, X., Wang, J. and Long, D. (2015) Incorporation of β-Sitosterol into the Membrane Prevents Tumor Necrosis Factor-α-Induced Nuclear Factor-κB Activation and Gonadotropin-Releasing Hormone Decline. Steroids, 96, 1-6. [Google Scholar] [CrossRef] [PubMed]
[10] Weitzmann, M.N. and Pacifici, R. (2006) Estrogen Deficiency and Bone Loss: An Inflammatory Tale. Journal of Clinical Investigation, 116, 1186-1194. [Google Scholar] [CrossRef] 
[11] McLean, R.R. (2009) Proinflammatory Cytokines and Osteoporosis. Cur-rent Osteoporosis Reports, 7, 134-139. [Google Scholar] [CrossRef] [PubMed]
[12] Chow, J., Tobias, J.H. and Colston, K.W. (1992) Estrogen Main-tains Trabecular Bone Volume in Rats Not Only by Suppression of Bone Resorption but Also by Stimulation of Bone Formation. Journal of Clinical Investigation, 89, 74-78. [Google Scholar] [CrossRef] 
[13] Bajbouj, K., Shafarin, J., Abdalla, M.Y., et al. (2017) Estrogen-Induced Disruption of Intracellular Iron Metabolism Leads to Oxidative Stress, Membrane Damage, and Cell Cycle Arrest in MCF-7 Cells. Tumor Biology, 39, Article ID: 1010428317726184. [Google Scholar] [CrossRef] [PubMed]
[14] Badenhorst, C.E., Forsyth, A.K. and Govus, A.D. (2022) A Contemporary Understanding of Iron Metabolism in Active Premenopausal Females. Frontiers in Sports and Active Liv-ing, 4, Article 903937. [Google Scholar] [CrossRef] [PubMed]
[15] 禄林, 高超, 王啸, 等. 雌激素减少对大鼠铁代谢的影响[J]. 中国骨质疏松杂志, 2014, 20(2): 115-119, 124.
[16] 费蓓蓓. 雌激素对“铁蓄积导致骨代谢异常”的影响及作用机制的研究[D]: [博士学位论文]. 苏州: 苏州大学, 2017.
[17] Liu, L.-L., Liu, G.-W., Liu, H., Zhao, K. and Xu, Y.-J. (2021) Iron Accumulation Deteriorated Bone Loss in Estrogen-Deficient Rats. Journal of Orthopaedic Surgery and Re-search, 16, Article No. 525. [Google Scholar] [CrossRef] [PubMed]
[18] Jian, J., Pelle, E. and Huang, X. (2009) Iron and Menopause: Does Increased Iron Affect the Health of Postmenopausal Women? Antioxidants & Redox Signaling, 11, 2939-2943. [Google Scholar] [CrossRef] [PubMed]
[19] Zacharski, L.R., Ornstein, D.L., Woloshin, S. and Schwartz, L.M. (2000) Association of Age, Sex, and Race with Body Iron Stores in Adults: Analysis of NHANES III Data. American Heart Journal, 140, 98-104. [Google Scholar] [CrossRef] [PubMed]
[20] Kato, I., Dnistrian, A., Schwartz, M., et al. (2000) Risk of Iron Overload among Middle-Aged Women. International Journal for Vitamin and Nutrition Research, 70, 119-125. [Google Scholar] [CrossRef] [PubMed]
[21] 张伟, 王兵, 张林林, 等. 绝经后股骨颈骨折股骨头骨铁含量、血清铁蛋白与骨密度相关性研究[J]. 中华骨科杂志, 2014, 34(1): 39-47.
[22] Kim, B.-J., Ahn, S.H., Bae, S.J., et al. (2012) Iron Overload Accelerates Bone Loss in Healthy Postmenopausal Women and Middle-Aged Men: A 3-Year Ret-rospective Longitudinal Study. Journal of Bone and Mineral Research, 27, 2279-2290. [Google Scholar] [CrossRef] [PubMed]
[23] Huang, X., Xu, Y. and Partridge, N.C. (2013) Dancing with Sex Hormones, Could Iron Contribute to the Gender Difference in Osteoporosis? Bone, 55, 458-460. [Google Scholar] [CrossRef] [PubMed]
[24] Jia, P., Xu, Y.J., Zhang, Z.L., et al. (2012) Ferric Ion Could Facil-itate Osteoclast Differentiation and Bone Resorption through the Production of Reactive Oxygen Species Journal of Or-thopaedic Research, 30, 1843-1852. [Google Scholar] [CrossRef] [PubMed]
[25] Ishii, K.-A., Fumoto, T., Iwai, K., et al. (2009) Coordination of PGC-1β and Iron Uptake in Mitochondrial Biogenesis and Osteoclast Activation. Nature Medicine, 15, 259-266. [Google Scholar] [CrossRef] [PubMed]
[26] Ni, S., Yuan, Y., Qian, Z., et al. (2021) Hypoxia Inhibits RANKL-Induced Ferritinophagy and Protects Osteoclasts from Ferroptosis. Free Radical Biology and Medicine, 169, 271-282. [Google Scholar] [CrossRef] [PubMed]
[27] Florencio-Silva, R., Sasso, G.R., Sasso-Cerri, E., et al. (2015) Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Research Interna-tional, 2015, Article ID: 421746. [Google Scholar] [CrossRef] [PubMed]
[28] Zhao, G.-Y., Zhao, L.-P., He, Y.-F., et al. (2012) A Comparison of the Biological Activities of Human Osteoblast hFOB1.19 between Iron Excess and Iron Deficiency. Biological Trace Ele-ment Research, 150, 487-495. [Google Scholar] [CrossRef] [PubMed]
[29] Edwards III, D.F., Miller, C.J., Quintana-Martinez, A., et al. (2021) Differential Iron Requirements for Osteoblast and Adipocyte Differentiation. JBMR Plus, 5, e10529. [Google Scholar] [CrossRef] [PubMed]
[30] Balogh, E., Tolnai, E., Nagy, B., et al. (2016) Iron Overload Inhibits Os-teogenic Commitment and Differentiation of Mesenchymal Stem Cells via the Induction of Ferritin. Biochimica et Bio-physica Acta (BBA)-Molecular Basis of Disease, 1862, 1640-1649. [Google Scholar] [CrossRef] [PubMed]
[31] Liu, F., Zhang, W.-L., Meng, H.-Z., Cai, Z.-Y. and Yang, M.-W. (2017) Regulation of DMT1 on Autophagy and Apoptosis in Osteoblast. International Journal of Medical Sciences, 14, 275-283. [Google Scholar] [CrossRef] [PubMed]
[32] Hentze, M.W., Muckenthaler, M.U., Galy, B. and Camaschella, C. (2010) Two to Tango: Regulation of Mammalian Iron Metabolism. Cell, 142, 24-38. [Google Scholar] [CrossRef] [PubMed]
[33] Vogt, A.-C.S., Arsiwala, T., Mohsen, M., et al. (2021) On Iron Metabolism and Its Regulation. International Journal of Molecular Sciences, 22, Article No. 4591. [Google Scholar] [CrossRef] [PubMed]
[34] Kowdley, K.V., Gochanour, E.M., Sundaram, V., Shah, R.A. and Handa, P. (2021) Hepcidin Signaling in Health and Disease: Ironing Out the Details. Hepatology Communications, 5, 723-735. [Google Scholar] [CrossRef] [PubMed]
[35] Tsay, J., Yang, Z., Ross, F.P., et al. (2010) Bone Loss Caused by Iron Overload in a Murine Model: Importance of Oxidative Stress. Blood, 116, 2582-2589. [Google Scholar] [CrossRef] [PubMed]
[36] Zhang, W., Xu, J., Qiu, J., et al. (2018) Novel and Rapid Os-teoporosis Model Established in Zebrafish Using High Iron Stress. Biochemical and Biophysical Research Communica-tions, 496, 654-660. [Google Scholar] [CrossRef] [PubMed]
[37] Shen, G.S., Yang, Q., Jian, J.L., et al. (2014) Hepcidin1 Knockout Mice Display Defects in Bone Microarchitecture and Changes of Bone Formation Markers. Calcified Tissue Internation-al, 94, 632-639. [Google Scholar] [CrossRef] [PubMed]
[38] Sun, L., Guo, W., Yin, C., et al. (2014) Hepcidin Deficiency Un-dermines Bone Load-Bearing Capacity through Inducing Iron Overload. Gene, 543, 161-165. [Google Scholar] [CrossRef] [PubMed]
[39] Guggenbuhl, P., Fergelot, P., Doyard, M., et al. (2011) Bone Sta-tus in a Mouse Model of Genetic Hemochromatosis. Osteoporosis International, 22, 2313-2319. [Google Scholar] [CrossRef] [PubMed]
[40] Doyard, M., Chappard, D., Leroyer, P., et al. (2016) Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss. PLOS ONE, 11, e0148292. [Google Scholar] [CrossRef] [PubMed]
[41] Jiang, Y., Yan, Y., Wang, X., Zhu, G. and Xu, Y.-J. (2016) Hepcidin Inhibition on the Effect of Osteogenesis in Zebrafish. Biochemical and Biophysical Research Communications, 476, 1-6. [Google Scholar] [CrossRef] [PubMed]
[42] 王冰, 徐又佳, 钱忠明. 铁与骨代谢研究的新进展[J]. 中国骨质疏松杂志, 2007, 13(10): 743-745.
[43] Cornish, J., Callon, K.E., Naot, D., et al. (2004) Lactoferrin Is a Po-tent Regulator of Bone Cell Activity and Increases Bone Formation in Vivo. Endocrinology, 145, 4366-4374. [Google Scholar] [CrossRef] [PubMed]
[44] Hou, J.-M., Xue, Y. and Lin, Q.-M. (2012) Bovine Lactoferrin Im-proves Bone Mass and Microstructure in Ovariectomized Rats via OPG/RANKL/RANK Pathway. Acta Pharmacologica Sinica, 33, 1277-1284. [Google Scholar] [CrossRef] [PubMed]
[45] Kang, H., Yan, Y., Jia, P., et al. (2016) Desferrioxamine Reduces Ultra-high-Molecular-Weight Polyethylene-Induced Osteolysis by Restraining Inflammatory Osteoclastogenesis via Heme Oxygenase-1. Cell Death & Disease, 7, e2435. [Google Scholar] [CrossRef] [PubMed]
[46] Guo, J.-P., Pan, J.-X., Xiong, L., et al. (2015) Iron Chelation Inhibits Osteoclastic Differentiation in Vitro and in Tg2576 Mouse Model of Alzheimer’s Disease. PLOS ONE, 10, e0139395. [Google Scholar] [CrossRef] [PubMed]
[47] Yu, H., Yang, C., Jian, L., et al. (2019) Sulfasalazine-Induced Ferroptosis in Breast Cancer Cells Is Reduced by the Inhibitory Effect of Estrogen Receptor on the Transferrin Receptor. Oncology Reports, 42, 826-838. [Google Scholar] [CrossRef] [PubMed]
[48] Kajarabille, N. and Latunde-Dada, G.O. (2019) Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators. International Journal of Molecular Sciences, 20, Article No. 4968. [Google Scholar] [CrossRef] [PubMed]
[49] Cen, W.-J., Feng, Y., Li, S.-S., et al. (2018) Iron Overload Induces G1 Phase Arrest and Autophagy in Murine Preosteoblast Cells. Journal of Cellular Physiology, 233, 6779-6789. [Google Scholar] [CrossRef] [PubMed]
[50] Zhang, H., Wang, A., Shen, G., et al. (2021) Hepcidin-Induced Reduction in Iron Content and PGC-1β Expression Negatively Regulates Osteoclast Differentiation to Play a Protective Role in Post-menopausal Osteoporosis. Aging, 13, 11296-11314. [Google Scholar] [CrossRef] [PubMed]
[51] Tian, Q., Qin, B., Gu, Y., et al. (2020) ROS-Mediated Necroptosis Is Involved in Iron Overload-Induced Osteoblastic Cell Death. Oxida-tive Medicine and Cellular Longevity, 2020, Article ID: 1295382. [Google Scholar] [CrossRef] [PubMed]
[52] 王啸, 林华, 徐又佳. NF-κB通路在骨质疏松伴铁蓄积中的潜在作用[J]. 中华内分泌代谢杂志, 2015, 31(2): 192-194.
[53] 程千. 铁蓄积对骨代谢的影响及相关机制的基础和临床研究[D]: [博士学位论文]. 苏州: 苏州大学, 2017: 1-114.
[54] 彭斯伟, 宋敏, 范凯, 等. 铁代谢与骨质疏松症的相关因素研究现状[J]. 中国骨质疏松杂志, 2021, 27(12): 1868-1872.
[55] Yang, Q., Jian, J., Abramson, S.B. and Huang, X. (2011) Inhibitory Effects of Iron on Bone Morphogenetic Protein 2-Induced Osteoblastogenesis. Journal of Bone and Mineral Research, 26, 1188-1196. [Google Scholar] [CrossRef] [PubMed]
[56] Rauner, M., Baschant, U., Roetto, A., et al. (2019) Transferrin Receptor 2 Controls Bone Mass and Pathological Bone Formation via BMP and Wnt Signaling. Nature Metabolism, 1, 111-124. [Google Scholar] [CrossRef] [PubMed]
[57] Huh, J.-E., Shin, J.H., Jang, E.S., et al. (2016) Sirtuin 3 (SIRT3) Maintains Bone Homeostasis by Regulating AMPK-PGC-1β Axis in Mice. Scientific Reports, 6, Article No. 22511. [Google Scholar] [CrossRef] [PubMed]
[58] Zhang, J., Zheng, L., Wang, Z., et al. (2019) Lowering Iron Level Protects against Bone Loss in Focally Irradiated and Contralateral Femurs through Distinct Mechanisms. Bone, 120, 50-60. [Google Scholar] [CrossRef] [PubMed]

为你推荐